Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-08

FDA Approved: SCENESSE — Original Application (CLINUVEL INC.)

View source ↗

Summary

FDA approved SCENESSE (afamelanotide) as the original application for adults with erythropoietic protoporphyria to increase tolerance to sunlight and reduce pho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SCENESSE (afamelanotide)

Snippet

ORIG AP for SCENESSE (AFAMELANOTIDE)